Imagine a treatment that not only helps manage diabetes but also holds the potential to reverse kidney failure — what was once thought to be impossible. The recent FLOW study has remarkable groundbreaking evidence that GLP-1 receptor agonists can significantly improve kidney function in chronic kidney disease (CKD) patients. And while researchers try to understand […]
weightloss
How GLP-1 Agonists May Improve NASH
Have you heard of fatty liver disease? Well, fatty liver disease is just what it sounds like—it’s when fat builds up in the liver and starts causing issues. The official name for it is “nonalcoholic fatty liver disease,” or NAFLD for short. Now, if that fat buildup leads to inflammation, it’s called “nonalcoholic steatohepatitis,” or […]
Switching From Semaglutide to Tirzepatide
Someone might switch from semaglutide to tirzepatide to achieve greater weight loss or improve blood sugar control. Tirzepatide has been shown to be more effective for some people because it works on two different hormones, GLP-1 and GIP. This combination can lead to better results in managing weight and overall health. Additionally, if a person […]
Tirzepatide for the Treatment of Obstructive Sleep Apnea
Imagine waking up refreshed after a full night’s sleep, free from the constant interruptions of obstructive sleep apnea (OSA). Now, imagine treating your OSA without relying on a bulky CPAP machine but with a convenient once-weekly injectable medication instead. Enter tirzepatide, the breakthrough peptide originally designed for diabetes and weight loss, is now making waves […]
Differences Between Semaglutide and Tirzepatide
Two of the most promising treatments for obesity in recent years are semaglutide, a GLP-1 agonist, and tirzepatide, a dual GLP-1/GIP agonist. These peptides have garnered attention for their impressive efficacy in weight loss and metabolic improvement, but they differ in their mechanisms, dosing, side effects, and outcomes. In this podcast, we’ll explore how these […]
Debunking the Myth: “You Can’t Stop Taking GLP-1 Agonists”
One common misconception about GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Zepbound), is that once you start taking them, you can never stop. This myth can deter individuals from considering these highly effective medications for weight loss. In this podcast, we’ll debunk this myth and provide a clearer understanding of how GLP-1 agonists can […]